centrotherm international stock has barely budged in recent weeks, yet the latest half year numbers land like a cold splash for anyone focused on profitability. Net income for H1 2026 came in at €2.248 million on revenue of €83.36 million, a far thinner cushion than last year’s semiconductor upswing suggested. The real story for long term holders is the tension between that squeeze and a trailing P/E of 10.1x, alongside a discounted cash flow value that sits very far above the current €9.25 share price.
Is centrotherm international a rare deep-value case, or is that huge gap between earnings pressure and the €108.77 DCF figure sending a warning signal instead? Compare the current €9.25 share price with our valuation analysis for centrotherm international
Prefer clear charts instead of another wall of earnings tables and ratios? Get a full visual view of centrotherm international’s valuation picture in the company report for centrotherm international.
For a bullish view on centrotherm international, the appeal is the exposure to solar, power semiconductors and broader electrification equipment. Recent figures do not fully back that optimism. Revenue of €83.36 million for H1 2026 sits well below the prior year and net income of €2.248 million compresses basic EPS to €0.106228. The share price has been broadly flat over 7 and 30 days, with a small decline over 90 days. That pattern suggests investors are not treating this as a clear growth winner right now.
Bears point to cyclicality and earnings fragility, and the latest results give that view some fuel. Revenue declined 21.7% year on year and net income fell 77.2%, pulling the trailing net margin down from 10.9% to 9.1%. That is a meaningful squeeze for a capital equipment supplier. At the same time, the stock has not collapsed, with a 90 day drop of only 3.1%. Current pricing hints that the market sees pressure, but not a broken business model.
With centrotherm international now trading on a 10.1x P/E while margins compress, the critical question is whether liquidity, leverage and cash generation still line up. Check the real balance sheet stress test in our financial health analysis of centrotherm international stock.If the wide gap between centrotherm international’s current €9.25 share price and its much higher DCF figure has your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch for a better entry point. Once you own it or have other holdings to manage, use the Portfolio Command Center to cut through noise and focus on the most important changes to your companies. For longer term decisions, tap into crowd insight by joining the Community and see how other investors are thinking about the same risks and opportunities. Spot potential catalysts and pressure points early so you can act faster and stay ahead of the market.
Fresh ideas move fast. Breakout themes gain momentum, early prices get caught re-rating, and under the radar stories do not stay quiet for long. Scan new lists now and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com